These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 1814747)
1. Correlation between the expression of the P21 ras oncogene product and the biological behavior of bladder tumors. Miao TJ; Wang Z; Sang N Eur Urol; 1991; 20(4):307-10. PubMed ID: 1814747 [TBL] [Abstract][Full Text] [Related]
2. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy. Zlotta AR; Noel JC; Fayt I; Drowart A; Van Vooren JP; Huygen K; Simon J; Schulman CC J Urol; 1999 Mar; 161(3):792-8. PubMed ID: 10022686 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of the ras oncogene expression in human bladder endoscopy specimens. Agnantis NJ; Constantinidou A; Poulios C; Pintzas A; Kakkanas A; Spandidos DA Eur J Surg Oncol; 1990 Apr; 16(2):153-60. PubMed ID: 2182341 [TBL] [Abstract][Full Text] [Related]
4. [Oncogene ras P 21 expression and DNA ploidy in human bladder tumor]. Wang Z Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):245-8. PubMed ID: 1806342 [TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemical studies of ras oncogene product p21 in human ovarian tumors]. Yaginuma Y; Yamashita K Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1409-16. PubMed ID: 2685141 [TBL] [Abstract][Full Text] [Related]
6. [Expression of oncogene ras product p21 protein in the tissues of penis cancer and its surrounding tissues]. Xin J; Wang X; Meng S Zhonghua Wai Ke Za Zhi; 1998 May; 36(5):310-1. PubMed ID: 11825397 [TBL] [Abstract][Full Text] [Related]
7. [Expression of mutant P53 gene protein product in human bladder carcinoma]. Ye DW Zhonghua Wai Ke Za Zhi; 1993 Aug; 31(8):484-6. PubMed ID: 8112175 [TBL] [Abstract][Full Text] [Related]
8. [Expression of ras oncogene p21 in relation to prognostic factors of human breast cancer]. Nishimura R; Nagao K; Miyayama H; Matsuda M; Baba K; Matsuoka Y; Ueno Y; Yamashita H; Nomura K; Ichiguchi O Gan To Kagaku Ryoho; 1991 Oct; 18(13):2271-5. PubMed ID: 1656890 [TBL] [Abstract][Full Text] [Related]
9. Ras p21 immunostaining in early stage squamous cervical carcinoma: relationship with lymph nodal involvement and 72 kDa-metalloproteinase index. Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Nictolis MD; Romanini C; Biagini G Anticancer Res; 1998; 18(1B):609-13. PubMed ID: 9568185 [TBL] [Abstract][Full Text] [Related]
10. Ha-ras oncogene product in human oral squamous cell carcinoma. Oku N; Shimada K; Itoh H Kobe J Med Sci; 1989 Dec; 35(5-6):277-86. PubMed ID: 2699627 [TBL] [Abstract][Full Text] [Related]
11. Expression of ras p21 oncogene product on human bladder tumors. Moriyama N; Umeda T; Akaza H; Taniguchi J; Kitamura T; Murakami T; Kawabe K; Aso Y Urol Int; 1989; 44(5):260-3. PubMed ID: 2678672 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the expression of a ras protein with a molecular weight of 21,000 by human breast cancer. Clair T; Miller WR; Cho-Chung YS Cancer Res; 1987 Oct; 47(20):5290-3. PubMed ID: 3308076 [TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal stromal tumors express ras oncogene: a potential role for diagnosis and treatment. Blair SL; Al-Refaie WB; Wang-Rodriguez J; Behling C; Ali MW; Moossa AR Arch Surg; 2005 Jun; 140(6):543-7; discussion 547-8. PubMed ID: 15967901 [TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas. Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437 [TBL] [Abstract][Full Text] [Related]
15. [Expression of ras oncogene product P21 in thyroid tumors: an immunohistochemical study]. Gui K Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):140-2, 12. PubMed ID: 2163739 [TBL] [Abstract][Full Text] [Related]
16. [Expression of bcl-2 and p16 in transitional cell carcinoma of urinary bladder]. Leng J; Zhang Y; Yao X; Wen K Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):40-3. PubMed ID: 11831985 [TBL] [Abstract][Full Text] [Related]
17. Relationship between ras oncogene expression and clinical and pathological features of colonic carcinoma. Michelassi F; Grad G; Erroi F; Roncella M; Romagnoli J; Handcock M Hepatogastroenterology; 1990 Oct; 37(5):513-6. PubMed ID: 2253930 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa. Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348 [TBL] [Abstract][Full Text] [Related]
19. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker. Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N Urol J; 2009; 6(2):101-8. PubMed ID: 19472128 [TBL] [Abstract][Full Text] [Related]
20. Human mismatch repair gene (hMSH2) product expression in relation to recurrence of transitional cell carcinoma of the urinary bladder. Jin TX; Furihata M; Yamasaki I; Kamada M; Liang SB; Ohtsuki Y; Shuin T Cancer; 1999 Jan; 85(2):478-84. PubMed ID: 10023718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]